Preveceutical Medical Inc C.PREV

Alternate Symbol(s): PRVCF

Healthcare Biotechnology

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).

CSE:PREV - Post by User

Preveceutical Medical Inc

Bullboard Posts

Comment by opsd1on Apr 04, 2019 4:54pm

131 Views

Post# 29584385

RE:Big news for PREV

Vancouverbound wrote: Buying into PREV now after the Gault will be like buying Canopy when they started trading in the open market.... This will be HUGE!

From another board on the Internet...

Prev looks to make a potential 20% of a billion dollars a year which puts their stock price at around $2.00. yup $2.00 !!! It is estimated that annual production from the asterion Facility will be approximately 500,000 kg of medicinal cannabis product, having an export value in excess of $1 billion, with approximately 20,000 plants harvested per day.

Bullboard Posts

Eminent acquires promising Nevada gold project